v3.25.2
Condensed Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Gain/(Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023   59,921,002      
Beginning balance at Dec. 31, 2023 $ 473,576 $ 6 $ 972,973 $ 345 $ (499,748)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock under benefit plans (in shares)   397,540      
Issuance of common stock under benefit plans 1,879   1,879    
Stock-based compensation expense 9,666   9,666    
Net unrealized loss on short-term investments (834)     (834)  
Net loss (46,955)       (46,955)
Ending balance (in shares) at Mar. 31, 2024   60,318,542      
Ending balance at Mar. 31, 2024 437,332 $ 6 984,518 (489) (546,703)
Beginning balance (in shares) at Dec. 31, 2023   59,921,002      
Beginning balance at Dec. 31, 2023 473,576 $ 6 972,973 345 (499,748)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net unrealized loss on short-term investments (962)        
Net loss (102,809)        
Ending balance (in shares) at Jun. 30, 2024   60,425,144      
Ending balance at Jun. 30, 2024 392,678 $ 6 995,846 (617) (602,557)
Beginning balance (in shares) at Mar. 31, 2024   60,318,542      
Beginning balance at Mar. 31, 2024 437,332 $ 6 984,518 (489) (546,703)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock under benefit plans (in shares)   106,602      
Issuance of common stock under benefit plans 684   684    
Stock-based compensation expense 10,644   10,644    
Net unrealized loss on short-term investments (128)     (128)  
Net loss (55,854)       (55,854)
Ending balance (in shares) at Jun. 30, 2024   60,425,144      
Ending balance at Jun. 30, 2024 $ 392,678 $ 6 995,846 (617) (602,557)
Beginning balance (in shares) at Dec. 31, 2024 60,860,838 60,860,838      
Beginning balance at Dec. 31, 2024 $ 304,081 [1] $ 6 1,013,806 321 (710,052)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock under benefit plans (in shares)   525,345      
Issuance of common stock under benefit plans 498   498    
Stock-based compensation expense 8,913   8,913    
Net unrealized loss on short-term investments (162)     (162)  
Net loss (56,166)       (56,166)
Ending balance (in shares) at Mar. 31, 2025   61,386,183      
Ending balance at Mar. 31, 2025 $ 257,164 $ 6 1,023,217 159 (766,218)
Beginning balance (in shares) at Dec. 31, 2024 60,860,838 60,860,838      
Beginning balance at Dec. 31, 2024 $ 304,081 [1] $ 6 1,013,806 321 (710,052)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net unrealized loss on short-term investments (322)        
Net loss $ (99,466)        
Ending balance (in shares) at Jun. 30, 2025 61,386,183 61,386,183      
Ending balance at Jun. 30, 2025 $ 220,082 $ 6 1,029,595 (1) (809,518)
Beginning balance (in shares) at Mar. 31, 2025   61,386,183      
Beginning balance at Mar. 31, 2025 257,164 $ 6 1,023,217 159 (766,218)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock under benefit plans (in shares)   0      
Issuance of common stock under benefit plans 0   0    
Stock-based compensation expense 6,378   6,378    
Net unrealized loss on short-term investments (160)     (160)  
Net loss $ (43,300)       (43,300)
Ending balance (in shares) at Jun. 30, 2025 61,386,183 61,386,183      
Ending balance at Jun. 30, 2025 $ 220,082 $ 6 $ 1,029,595 $ (1) $ (809,518)
[1] The condensed balance sheet as of December 31, 2024 has been derived from the audited financial statements as of that date.